Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
XC

Xin Chen — 75 Patents

MEMetabolex: 13 patents #1 of 50Top 2%
OPOsi Pharmaceuticals: 11 patents #12 of 181Top 7%
Novartis Ag: 8 patents #480 of 5,128Top 10%
CUColumbia University: 8 patents #146 of 2,492Top 6%
CTCymabay Therapeutics: 7 patents #9 of 38Top 25%
AOArvinas Operations: 6 patents #10 of 34Top 30%
PTPalatin Technologies: 5 patents #12 of 30Top 40%
NINational Health Research Institutes: 3 patents #49 of 318Top 20%
SASanofi: 3 patents #505 of 1,881Top 30%
TPTranstech Pharma: 3 patents #33 of 65Top 55%
YUYale University: 3 patents #269 of 1,662Top 20%
BSBioinformatics Solutions: 2 patents #5 of 14Top 40%
UNUnknown: 1 patents #29,356 of 83,584Top 40%
DUDuke University: 1 patents #1,064 of 2,315Top 50%
UFUwm Research Foundation: 1 patents #57 of 154Top 40%
Overall (All Time): #25,505 of 4,157,543Top 1%
75 Patents All Time
Xin Chen has been granted 75 US patents while listed as an inventor at Metabolex. The first was granted in 2002 and the most recent in June 2025. Xin Chen ranks #25,505 of 4,157,543 US inventors in our database (top 0.61%). Patent records list Xin Chen in Changsha, CT, CN.

Issued Patents All Time

Showing 1–25 of 75 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12337009 Nucleotide derivatives and methods of use thereof Jingyue Ju, Xiaoxu Li, Zengmin Li, Min-Kang Hsieh, Minchen Chien +8 more 2025-06-24
12312316 Compounds and methods for the targeted degradation of androgen receptor Andrew P. Crew, Hanqing Dong, Yimin Qian, Lawrence B. Snyder 2025-05-27
12264157 Compounds and methods for the enhanced degradation of targeted proteins Andrew P. Crew, Craig M. Crews, Hanqing Dong, Caterina Ferraro, Yimin Qian +6 more 2025-04-01
12188086 Nucleotide analogues and use thereof for nucleic acid sequencing and analysis preliminary class Jingyue Ju, Xiaoxu Li, Shiv Kumar, James J. Russo, Minchen Chien +6 more 2025-01-07
12157737 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof Mallesh BUSHABOINA, Atwood Kim CHEUNG, Andrew James Culshaw, Timothy Brian HURLEY, Nancy LABBE-GIGUERE +9 more 2024-12-03 $83,627,000
12122761 2-azaspiro[3.4]octane derivatives as M4 agonists Amy Calhoun, Kevin Matthew Gardinier, Edward Charles Hall, Keith Jendza, Nancy LABBE-GIGUERE +7 more 2024-10-22 $90,116,000
12018325 3′-O-modified nucleotide analogues with different cleavable linkers for attaching fluorescent labels to the base for DNA sequencing by synthesis Jingyue Ju, Xiaoxu Li, Shiv Kumar, James J. Russo, Minchen Chien 2024-06-25 $773,000
12006540 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis Jingyue Ju, Xiaoxu Li, Zengmin Li, Shiv Kumar, Shundi Shi +8 more 2024-06-11 $599,000
11999999 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis Jingyue Ju, Xiaoxu Li, Zengmin Li, Shiv Kumar, Shundi Shi +8 more 2024-06-04 $741,000
11959137 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis Jingyue Ju, Xiaoxu Li, Zengmin Li, Shiv Kumar, Shundi Shi +8 more 2024-04-16 $521,000
11820778 2-azaspiro[3.4]octane derivatives as M4 agonists Amy Calhoun, Kevin Matthew Gardinier, Edward Charles Hall, Keith Jendza, Nancy LABBE-GIGUERE +7 more 2023-11-21 $66,467,000
11708366 Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof Mallesh BUSHABOINA, Atwood Kim CHEUNG, Andrew James Culshaw, Timothy Brian HURLEY, Nancy LABBE-GIGUERE +9 more 2023-07-25 $74,766,000
11694769 Systems and methods for de novo peptide sequencing from data-independent acquisition using deep learning Baozhen Shan, Ngoc Hieu Tran, Ming-Shuan Li, Lei Xin, Rui Qiao +1 more 2023-07-04
11644470 Systems and methods for de novo peptide sequencing using deep learning and spectrum pairs Rui Qiao, Ngoc Hieu Tran, Lei Xin, Baozhen Shan, Ali Ghodsi +1 more 2023-05-09
11548865 2-azaspiro[3.4]octane derivatives as M4 agonists Amy Calhoun, Kevin Matthew Gardinier, Edward Charles Hall, Keith Jendza, Nancy LABBE-GIGUERE +7 more 2023-01-10 $39,770,000
11512083 Compounds and methods for the enhanced degradation of targeted proteins Andrew P. Crew, Craig M. Crews, Hanqing Dong, Caterina Ferraro, Yimin Qian +5 more 2022-11-29
11485742 2-azaspiro[3.4]octane derivatives as M4 agonists Amy Calhoun, Kevin Matthew Gardinier, Edward Charles Hall, Keith Jendza, Nancy LABBE-GIGUERE +7 more 2022-11-01 $120,472,000
11427548 Compounds and methods for the targeted degradation of androgen receptor Andrew P. Crew, Hanqing Dong, Jing Wang, Yimin Qian, Kurt Zimmermann +2 more 2022-08-30
11389480 Human monoclonal antibody targeting TNFR2 for cancer immunotherapy Joost Oppenheim, Dimiter S. Dimitrov, De Yang, Zhongyu Zhu 2022-07-19
11352351 Compounds and methods for the targeted degradation of androgen receptor Meizhong Jin, Andrew P. Crew, Hanqing Dong, Jing Wang, Yimin Qian 2022-06-07
11278524 Formulations and methods for the treatment of cancers Dean G. Tang 2022-03-22
11266673 Nucleotide derivatives and methods of use thereof Jingyue Ju, Xiaoxu Li, Zengmin Li, Min-Kang Hsieh, Minchen Chien +8 more 2022-03-08
11085076 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis Jingyue Ju, Xiaoxu Li, Zengmin Li, Shiv Kumar, Shundi Shi +8 more 2021-08-10
10730870 Compounds and methods for the enhanced degradation of targeted proteins Andrew P. Crew, Craig M. Crews, Hanqing Dong, Caterina Ferraro, Yimin Qian +6 more 2020-08-04
10632171 Melanocortin receptor-specific peptides Yi-Qun Shi, Shubh D. Sharma, John H. Dodd, Wei Yang 2020-04-28 $1,673,000